TIRZEPATIDE : ONE DETAILED LOOK

The novel class of GLP-1 agonist medication and GIP co-agonist medications, including tirzepatide, semaglutide, and the relatively introduced retatrutide, provide groundbreaking progress in the control. Although all three operate by modulating glucose levels , they vary in their unique mechanisms